Dr. Ram Ramabhadran is the  Acting Division Director of the Integrated systems Toxicology Division (ISTD) of Environmental Protection Agency ′s (EPA′s) National Health and Ecological Effects Laboratory (NHEERL). He obtained his Ph.D. in Molecular Biology from the University of Texas at Dallas (1975), followed by postdoctoral studies at  the Washington University School of Medicine in St. Louis. He has held several positions in pharmaceutical and biotechnology companies. He holds adjunct faculty appointments at the Division of Neurology at the Duke University Medical Center and in the Curriculum in Toxicology at the University of North Carolina, Chapel Hill.   

Rebecca L. Cunningham is a research assistant professor in the Department of Pharmacology and Neuroscience at the University of North Texas Health Science Center in Fort Worth TX.  She completed her B.S. in Psychology from Truman State University, Kirksville, MO in 2001 and received her Ph.D. in Biology with an emphasis on neurobiology from University of Texas at San Antonio, San Antonio, TX in 2006. Her postdoctoral training was completed in 2010 following two postdoctoral fellowships at University of Texas Health Science Center at San Antonio, TX and University of North Texas Health Science at Fort Worth, TX. She is a member of several organizations, such as American Physiological Society, Society for Neuroscience, Endocrine Society, and others. Recently, she received the Young Investigator Award by the American Physiological Society, Cell and Molecular Physiology Section. Her research has been focused on understanding the role of androgens and aging on dopaminergic neurodegeneration.


 

Dr. Ze-hua Liu is a research scientist in Department of Urban Engineering, Graduate School of Engineering, Osaka City University, Japan. He has received his B.S (Chemical Engineering, 1997-2001) from Xiangtan University, China, M.S (Biochemical Engineering, 2001-2004) from Beijing University of Chemical Engineering, China, and Ph.D (Urban Engineering, 2007.4-2010.3) from Osaka City University, Japan. For his excellent research during the doctoral study, he has been awarded as the 2009 National Award for Outstanding Self-financed Chinese Students Study Abroad by China Scholarship Council, for which no more than 500 Chinese students all over the world were selected at this year. He has published more than twenty peer-reviewed papers, among which two articles has been listed as the top 25 hottest articles in Science of the total environment. He is reviewers for several peer reviewed journals such as Science of the Total Environment, Environmental Science and Pollution Research, and Journal of Women’s Health.

Dr. Tomoshige Kino is  head of Unit on Molecular Hormone Action, Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. He has completed his B.A in Medicine in Chiba University, Chiba, Japan (1985). He received the Merck Senior Fellow Award from the Endocrine Society and 2 Merit Awards from Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. He is serving as an editorial board member of 2 reputed journals. He has currently 96 publications appeared in PUBMED, 16 book chapters and 1 book edition. Every year, he performs ~10-20 reviews requested by prestigious Journals.

Dr. Salman Azhar is a Professor in Department of Veterans Affairs Palo Alto Health Care System.He received his Ph.D. in 1973 at C.S.J.M. University, Kanpur. He is active member of many associations like The American Association for the Advancement of Science, The American Society for Biochemistry and Molecular Biology.

 

Dr. Vadlamudi received his doctorate in Molecular Biology from the University of Wyoming, Laramie, WY, USA in 1994. He completed his postdoctoral training at Harvard Medical School / Dana Farber Cancer Institute in 1997 and second postdoctoral training at UT MD Anderson Cancer Center in 1999. Dr. Vadlamudi is currently a Professor in the Dept of OB/GYN at UT Health Science Center, San Antonio, and is also a member of the Cancer Therapy and Research Center, San Antonio. Dr. Vadlamudi’s research has been focused on understanding the molecular mechanism of Estrogen Receptor (ER) Signal transduction. Dr. Vadlamudi research program is supported by the NIH, DOD and Susan G. Komen Research programs. Dr. Vadlamudi serves as a scientific reviewer for several grant-making agencies, including the NIH and DOD. He has published ~94 peer reviewed publications, serving as an editorial board member of three reputed journals and function as an adhoc reviewer of for a number journals.

He is an Associate Professor and Surgeon in the Department of Otorhinolaryngology – Head & Neck Surgery in Universiti Sains Malaysia.  He  held a number of professional posts in the national level over the years. He has published and presented in many scientific papers, both at the national and international level. He has also actively involved in services to many international professional communities as invited speakers and presenters. Till to date, he has organized more than 20 conferences with roles and responsibilities from organizing committee to organizing chairperson. He have contributed significantly to the successes of symposiums and workshops in my University and the Malaysian Society of Otorhinolaryngologists-Head and Neck Surgeons (MSO-HNS) Meetings.

Dr. Igor Butovich is an Associate Professor in the department of Ophthalmology Graduate School of Biomedical Sciences University of Texas Southwestern Medical Center Dallas,USA

Dr. Juan Ding received her B.S. degree from Tsinghua University, Beijing, China in 2004. She then studied in the Molecular and Cellular Biology program under the supervision of Dr. John Kopchick at Ohio University and received her Ph.D. in 2009. Her Ph.D. dissertation unraveled biomarkers of growth hormone and aging in a series of mouse models that showed excess or disrupted growth hormone signaling. As a post doctoral research associate, Dr. Ding focused on detecting growth hormone doping and discovered novel biomarkers of recombinant human growth hormone administration in healthy human subjects. Dr. Ding has published many original research articles as well as reviews and a book chapter on growth hormone, aging, proteomics and molecular biology. Currently Dr. Ding is working at Schepens Eye Research Institute at Harvard medical school to unravel the endocrine regulation of meibomian gland in dry eye disease.